Post Operative Pain of Root Canal Preparation With Wave One and Neolix in Acute Irreversible Pulpitis

NCT02952300 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2016-11-02

No results posted yet for this study

Summary

the aim in this prospective in vivo randomized clinical trial to evaluate the influence of instrumentation technique ( reciprocation single file (wave one ) versus rotation single file (neolix) ) on post operative pain ( incidence ,degree and duration ) after endodontic treatment in single rooted lower premolars with symptomatic irreversible pulpits.

According to the inclusion criteria the patients enrolled in the study and allocated randomly into two groups either Wave One (group A) or Neolix ( group B) the endodontic treatment is done at single visit. firstly the patient's medical and dental history is taken .the patient assign on informed consent. and then,anaesthetized and access cavity performed and root canal preparation is done by either two systems and then irrigation and obturation is done. the patient record the post operative pain in sheet with NRS after 6,12,24,48hr and the operator will recall the patient to check the records and follow up the patient.

Conditions

  • Pulpitis - Irreversible

Interventions

PROCEDURE

neolix

single rotation file

PROCEDURE

wave one

single reciprocation file

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • abeer marouzk, professor · faculty of oral and dental medicine -cairo university

  • alaa el baz, ass. professor · faculty of oral and dental medicine -cairo university

  • yasmin hassan yousief, resident · faculty of oral and dental medicine -cairo university

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2017-10-31
Completion
2018-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02952300 on ClinicalTrials.gov